Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • MIDDLEBROOK PHARMACEUTICAL I Financial Overview

  • Income Statement: MBRK

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 8.85 M 10.46 M -1.61 M -18.16%
    Gross Profit 898,038.00 3.42 M -2.52 M -280.79%
    Net Income Before Extra Items/Preferred Div -41.58 M -42.25 M 669,366.00 -1.61%
    Operating Income -34.10 M -40.12 M 6.02 M -17.64%
  • Cash Flow: MBRK

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 108.07 M 23.19 M 84.87 M 78.54%
    Net Cash Flow - Investing 55.50 M 834,473.00 54.67 M 98.50%
    Net Cash Flow/Operating Activities -24.00 M -35.26 M 11.26 M -46.94%
  • Balance Sheet: MBRK

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 95.19 M 23.67 M 71.53 M 75.14%
    Total Liabilities 23.26 M 22.18 M 1.09 M 4.67%
    Shareholders Equity 71.93 M -5.85 M 77.78 M 108.13%
  • Key Ratios / Statistics: MBRK

    • Valuation

      Price/Earnings (TTM) -2.34
      Price/Sales (TTM) 11.05
      Price/Book (MRQ) 2.66
      Price/Cash Flow (TTM)
    • Profitability

      Gross Margin 10.15
      Operating Margin -385.38
      Profit Margin -469.83
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 8.25
      Current Ratio (MRQ) 4.16
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -181.02
      Return on Assets (TTM) -101.73
      Return on Investments (TTM) -113.27